These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions]. Fu Q; Yao GY; Tang XL; Chen LR; Zheng ZX Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):34-40. PubMed ID: 17575691 [TBL] [Abstract][Full Text] [Related]
23. Uncovering the genomic heterogeneity of multifocal breast cancer. Desmedt C; Fumagalli D; Pietri E; Zoppoli G; Brown D; Nik-Zainal S; Gundem G; Rothé F; Majjaj S; Garuti A; Carminati E; Loi S; Van Brussel T; Boeckx B; Maetens M; Mudie L; Vincent D; Kheddoumi N; Serra L; Massa I; Ballestrero A; Amadori D; Salgado R; de Wind A; Lambrechts D; Piccart M; Larsimont D; Campbell PJ; Sotiriou C J Pathol; 2015 Aug; 236(4):457-66. PubMed ID: 25850943 [TBL] [Abstract][Full Text] [Related]
24. High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history. Csokay B; Udvarhelyi N; Sulyok Z; Besznyak I; Ramus S; Ponder B; Olah E Cancer Res; 1999 Mar; 59(5):995-8. PubMed ID: 10070953 [TBL] [Abstract][Full Text] [Related]
25. PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast. Li H; Zhu R; Wang L; Zhu T; Li Q; Chen Q; Wang H; Zhu H Exp Mol Pathol; 2010 Feb; 88(1):150-5. PubMed ID: 19818761 [TBL] [Abstract][Full Text] [Related]
26. [The male breast carcinoma: a center experience]. Ludwig S; Hauss JP; Hohlfeld S; Hildebrandt G; Horn LC; Leinung S Zentralbl Chir; 2007 Oct; 132(5):386-90. PubMed ID: 17907079 [TBL] [Abstract][Full Text] [Related]
27. Histological and immuno-histochemical study of male breast carcinoma in Northern Pakistan. Sharif MA; Mamoon N; Arif A; Mushtaq S; Khadim MT J Pak Med Assoc; 2009 Feb; 59(2):67-71. PubMed ID: 19260565 [TBL] [Abstract][Full Text] [Related]
28. Hormone signaling via androgen receptor affects breast cancer and prostate cancer in a male patient: A case report. Takuwa H; Tsuji W; Shintaku M; Yotsumoto F BMC Cancer; 2018 Dec; 18(1):1282. PubMed ID: 30577860 [TBL] [Abstract][Full Text] [Related]
29. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A. Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL; Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925 [TBL] [Abstract][Full Text] [Related]
30. Hemochromatosis gene mutations among Finnish male breast and prostate cancer patients. Syrjäkoski K; Fredriksson H; Ikonen T; Kuukasjärvi T; Autio V; Matikainen MP; Tammela TL; Koivisto PA; Schleutker J Int J Cancer; 2006 Jan; 118(2):518-20. PubMed ID: 16003728 [TBL] [Abstract][Full Text] [Related]
31. HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry. Quenneville LA; Phillips KA; Ozcelik H; Parkes RK; Knight JA; Goodwin PJ; Andrulis IL; O'Malley FP Cancer; 2002 Nov; 95(10):2068-75. PubMed ID: 12412159 [TBL] [Abstract][Full Text] [Related]
32. Can cyclo-oxygenase-2 be a useful prognostic and risk stratification marker in breast cancer? Jana D; Sarkar DK; Maji A; Chikkala BR; Hassanujjaman S; Mukhopadhyay M; Ganguly S J Indian Med Assoc; 2012 Jul; 110(7):429-33. PubMed ID: 23520664 [TBL] [Abstract][Full Text] [Related]
33. Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma. Tokunaga E; Oki E; Kimura Y; Yamanaka T; Egashira A; Nishida K; Koga T; Morita M; Kakeji Y; Maehara Y Breast Cancer Res Treat; 2007 Mar; 101(3):249-57. PubMed ID: 17006756 [TBL] [Abstract][Full Text] [Related]
34. [Clinicopathologic analysis of the nipple-areolar complex occult involvement in early stage breast carcinoma]. Wang SY; Peng DF; Cai ZG; Zhang RZ; Yao TJ; Zhang H; Yang M; Dong HM Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):203-6. PubMed ID: 18756937 [TBL] [Abstract][Full Text] [Related]
35. Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy? Murthy V; Chamberlain RS Clin Breast Cancer; 2013 Jun; 13(3):180-7. PubMed ID: 23357305 [TBL] [Abstract][Full Text] [Related]
36. Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence. Jeschke U; Mylonas I; Kunert-Keil C; Dazert E; Shabani N; Werling M; Kuhn C; Janni W; Gerber B; Friese K Oncol Rep; 2005 Mar; 13(3):413-9. PubMed ID: 15706409 [TBL] [Abstract][Full Text] [Related]
37. Analysis of familial male breast cancer for germline mutations in CHEK2. Sodha N; Wilson C; Bullock SL; Phillimore H; Houlston RS; Eeles RA Cancer Lett; 2004 Nov; 215(2):187-9. PubMed ID: 15488637 [TBL] [Abstract][Full Text] [Related]
38. [Breast carcinoma in the man. Current results from the viewpoint of clinic and pathology]. Prechtel K; Prechtel V Pathologe; 1997 Jan; 18(1):45-52. PubMed ID: 9157404 [TBL] [Abstract][Full Text] [Related]
39. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Saal LH; Holm K; Maurer M; Memeo L; Su T; Wang X; Yu JS; Malmström PO; Mansukhani M; Enoksson J; Hibshoosh H; Borg A; Parsons R Cancer Res; 2005 Apr; 65(7):2554-9. PubMed ID: 15805248 [TBL] [Abstract][Full Text] [Related]
40. Breast carcinoma in women 35 years and younger: a pathological study. Fernandopulle SM; Cher-Siangang P; Tan PH Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]